Knowledge, Attitude, and Perception Towards COVID-19 Vaccines in Thailand
Article Sidebar
Main Article Content
Abstract
Background and Objectives: Nowadays, several COVID-19 vaccines have been produced and developed. However, to implement an effective vaccination strategy, it is necessary to know the knowledge, attitude, and perception towards COVID-19 vaccines among the Thai population.
Design: Cross-sectional, quantitative, and descriptive study
Methods: An E-survey questionnaire was conducted from 3 July – 7 August 2021 with 893 participants.
Results: The mean score of knowledge was 2.8 (± SD 1.1) out of 5. The mean score of attitude was 10.2 (± SD 1.8) out of 12. More than half (65.5%) of participants did not agree or were not sure whether or not “the newly discovered COVID-19 vaccine is safe”. The top three reasons for COVID-19 vaccine hesitation were 1) not sure about side effects (34.8%), 2) not sure about efficacy and quality (34.4%), and 3) not sure about the brand, or vaccine manufactured technology, or prefer other kind of vaccines such as mRNA vaccine (24.0%). For the perception of COVID-19, most participants thought that there were vaccine side effects (90.8%), vaccines should be distributed to everyone for free (98.2%), everyone should get vaccinated (88.9%), and medical staff should be the priority to get the vaccination.
Conclusions: It was found that the knowledge of COVID-19 was moderate, and the attitude score was primarily positive. Thus more information on the efficacy and safety of vaccines should be disseminated.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The content and information in articles published in the PCFM journal are solely the opinions and responsibilities of the authors. The journal's editorial board does not necessarily agree with or share any responsibility for them.
All articles, information, content, images, etc., published in the PCFM journal are the copyright of the PCFM journal. If any individual or organization wishes to reproduce, distribute, or use any part or the entirety of the content, they must obtain written permission from the PCFM journal beforehand.
References
World Health Organization (WHO). Naming the coronavirus disease (COVID-19) and the virus that causes it. [internet]. 2020[cited 9 March 2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395(10225):689-97.
กรมควบคุมโรค กระทรวงสาธารณสุข. โรคติดเชื้อไวรัสโคโรนา 2019 (COVID-19). [internet]. 2563 [เข้าถึงเมื่อ 10 เมย 2563]. เข้าถึงได้จาก: https://ddc.moph.go.th/viralpneumonia/
World Health Organization (WHO). Coronavirus disease (COVID-19) dashboard 2021 [internet]. 2021 [cited 17 Apr 2021]. Available from: https://covid19.who.int.
Center for Disease Control and Prevention (CDC). Ways COVID-19 Spreads. [internet] 2020[cited 14 Apr 2021]. Available from htttp://www.cdc.gov/coronavirus/2019-ncov/science/science-agenda-covid19.html
Rahman HS, Aziz MS, Hussein RH, Othman HH, Salih Omer SH, Khalid ES, et al. The transmission modes and sources of COVID-19: A systematic review. International Journal of Surgery Open. 2020;26:125-36.
Liu J, Liao X, Qian S, Yuan J, Wang F, Liu Y, et al. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis. 2020;26(6):1320-3.
Li X, Luk HKH, Lau SKP, Woo PCY. Human Coronaviruses: General Features. Reference Module in Biomedical Sciences: Elsevier; 2019.
Park S. Epidemiology, virology, and clinical features of severe acute respiratory syndrome-coronavirus-2 (SARS-COV-2; Coronavirus Disease-19). Clinical and Experimental Pediatrics. 2020;63.
Wang Y, Tian H, Zhang L, Zhang M, Guo D, Wu W, et al. Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China. BMJ Glob Health. 2020;5(5).
Talic S, Shah S, Wild H, Gasevic D, Maharaj A, Ademi Z, et al. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis. Bmj. 2021;375:e068302.
Andrejko KL, Pry JM, Myers JF, Fukui N, DeGuzman JL, Openshaw J, et al. Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARS-CoV-2 Infection - California, February-December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(6):212-6.
World Health Organization (WHO). Coronavirus disease (COVID-19) Vaccines. [internet]. 2021 [cited 14 Apr 2021]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines
Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, et al. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). J Microbiol Biotechnol. 2020;30(3):313-24.
กรมควบคุมโรค กระทรวงสาธารณสุข. แนวทางการให้วัคซีนโควิด 19 ในสถานการณ์การระบาดปี 64 ของประเทศไทย.[internet]. 2563 [เข้าถึงเมื่อ 16 มีค 2563]. เข้าถึงได้จาก: https://ddc.moph.go.th/vaccine-covid19/
Islam MS, Siddique AB, Akter R, Tasnim R, Sujan MSH, Ward PR, et al. Knowledge, attitudes and perceptions towards COVID-19 vaccinations: a cross-sectional community survey in Bangladesh. medRxiv. 2021:2021.02.16.21251802.
Bhartiya S, Kumar N, Wadhwani M. Knowledge, attitude and practice towards COVID-19 vaccination acceptance in West India. International Journal Of Community Medicine And Public Health. 2021;9:303.
El-Elimat T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, Alali FQ. Acceptance and Attitudes Toward COVID-19 Vaccines: A Cross-Sectional Study from Jordan. medRxiv. 2020:2020.12.22.20248676.
Di Gennaro F, Murri R, Segala FV, Cerruti L, Abdulle A, Saracino A, et al. Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy. Viruses. 2021;13(3).
กรมควบคุมโรค และโครงการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ Health Intervention and Technology Assesment Program HITAP. ผลสำรวจความเห็นของบุคลากรทางการแพทย์และสาธารณสุขต่อการรับวัคซีนโควิด-19ในประเทศไทย.[internet]. 2564.[เข้าถึงเมื่อ 10 เมษ 2564] เข้าถึงได้จาก: https://www.hitap.net/wp-content/uploads/2021/03/PB_Covid-Vaccine-Demand-Web.pdf
